tiprankstipranks
Trending News
More News >
GenSight Biologics SA (FR:SIGHT)
:SIGHT
France Market

GenSight Biologics SA (SIGHT) Cash flow

Compare
3 Followers

GenSight Biologics SA Cash Flow

FR:SIGHT's free cash flow for Q2 2025 was €-2.46M. For the 2025 fiscal year, FR:SIGHT's free cash flow was decreased by €11.73M and operating cash flow was €-2.46M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
€ -12.94M€ -24.66M€ -33.75M€ -17.14M€ -15.04M
Investing Cash Flow
€ 17.00K€ 209.00K€ 172.00K€ -16.00K€ -376.00K
Financing Cash Flow
€ 13.54M€ 15.86M€ 95.00K€ 23.74M€ 33.86M
End Cash Position
€ 2.46M€ 2.13M€ 10.61M€ 44.29M€ 37.94M
Free Cash Flow
€ -12.94M€ -24.67M€ -34.01M€ -17.17M€ -15.05M
Currency in EUR

GenSight Biologics SA Cash Flow